Combinational Pretreatment of Colony-Stimulating Factor 1 Receptor Inhibitor and Triptolide Upregulates BDNF-Akt and Autophagic Pathways to Improve Cerebral Ischemia.

Mediators of Inflammation
Xiaoxue DuMarong Fang

Abstract

Ki20227, a selective inhibitor of colony-stimulating factor 1 receptor (CSF1R), has been suggested to regulate microglia inflammatory function and neuronal synaptic plasticity. Triptolide (TP) pretreatment has neuroprotective effects through its anti-inflammatory and antiapoptotic features in ischemic stroke mice. However, the underlying mechanism and pathway are presently unclear. We thus investigated the association between neuroprotective effects of combined TP and Ki20227 and BDNF-Akt and autophagy pathways. Ki20227 was administrated for 7 days, and TP was administered once 24 hours prior to building the ischemic stroke model in C57BL/6 mice. Behavioral tests, Golgi staining, immunofluorescence, and western blot analyses were employed to examine neuroprotective effects of TP and Ki20227. TP and Ki20227 pretreatments improved the neurobehavioral function in stroke mice. Synaptic protein expressions and density of dendritic spine density were upregulated in Ki20227 and TP pretreated stroke mice. Further, optimized integration of TP and Ki20227 pretreatments upregulated the NeuN expression and downregulated Iba1 expression after stroke. In addition, both TP and Ki20227 pretreatments significantly upregulated BDNF, p-Akt/Akt, a...Continue Reading

References

Aug 8, 2009·Stroke; a Journal of Cerebral Circulation·Ryotaro SaikiKazuei Igarashi
Apr 3, 2010·Journal of Neuroscience Methods·Hiromi ShiotsukiNobutaka Hattori
Jan 9, 2013·The Journal of Experimental Medicine·Jian LuoTony Wyss-Coray
Mar 24, 2015·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Yukihiro Hara
Apr 17, 2015·Journal of Neuroinflammation·Ting ZhangXiaomin Wang
May 23, 2015·Cerebral Cortex·Lei PeiYouming Lu
Sep 12, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ran LiTing Lei
Jan 15, 2018·Progress in Neurobiology·Pei WangChao-Yu Miao
Feb 17, 2018·Acta Neuropathologica Communications·Nicolau BeckmannDerya R Shimshek
Apr 22, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Archana KumariRajesh K Singh
May 18, 2018·Science Translational Medicine·Ali AlawiehStephen Tomlinson
May 26, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sarbari SahaSujit K Bhutia
Jun 14, 2018·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Bowen LiuYonghua Zhao
Jun 16, 2018·Journal of Pharmacological and Toxicological Methods·Sayed Masoud HosseiniMohammad Ismail Zibaii
Jul 19, 2018·Behavioural Neurology·Yanhua QinMarong Fang
Feb 12, 2019·Journal of Neuroscience Research·K Duris, M Jurajda
Feb 28, 2019·Cell Biology International·Zhiying HuMarong Fang
Mar 2, 2019·Critical Reviews in Clinical Laboratory Sciences·Seyed Fazel NabaviSamira Shirooie
Mar 25, 2019·Journal of the Neurological Sciences·Kai HouYunman Li
Sep 11, 2019·Brain : a Journal of Neurology·Renzo MancusoV Hugh Perry
Jan 14, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Chien-Chin HsuHung-Jung Lin
Feb 26, 2020·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rebecca J HenryDavid J Loane

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Key Resources (RRID) Mentioned

AB_2224403
AB_10711040
AB_444362
AB_2286949
AB_2138153
AB_2630358
AB_881433
AB_2650499
AB_2810880
AB_2810879

Software Mentioned

Image
Pro Plus
ImageJ

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.